Anaplastic large cell lymphoma (ALCL), ALK-positive, is a subtype of non-Hodgkin lymphoma characterized by the presence of anaplastic large cells and the expression of the anaplastic lymphoma kinase (ALK) protein. This specific diagnosis indicates that the lymphoma is located in the intrapelvic lymph nodes. Accurate coding with ICD-10 Code C84.66 is essential for proper diagnosis, documentation, billing, and public health reporting, ensuring that patients receive appropriate treatment and care.
What is ICD-10 Code C84.66 for Anaplastic large cell lymphoma, ALK-pos, intrapelv nodes?
ICD-10 Code C84.66 represents Anaplastic large cell lymphoma, ALK-positive, specifically affecting the intrapelvic lymph nodes. This code is used when documenting cases of ALCL that are characterized by the presence of the ALK gene rearrangement, which is associated with a distinct clinical behavior and treatment response. It is crucial for accurate clinical documentation and billing, particularly in oncology settings.
ICD-10 Code C84.66 – Clinical Definition and Explanation of Anaplastic large cell lymphoma, ALK-pos, intrapelv nodes
Anaplastic large cell lymphoma, ALK-positive, is a rare and aggressive form of non-Hodgkin lymphoma that typically presents in younger patients. The condition is driven by genetic alterations involving the ALK gene, leading to uncontrolled cell proliferation. Prompt diagnosis and treatment are critical due to its aggressive nature.
Key Clinical Features:
- Presence of anaplastic large cells on histological examination.
- Positive ALK protein expression confirmed by immunohistochemistry.
- Commonly presents with lymphadenopathy, particularly in the pelvic region.
- May be associated with systemic symptoms such as fever, night sweats, and weight loss.
- Higher incidence in adolescents and young adults.
ICD-10 Code C84.66 for Anaplastic large cell lymphoma, ALK-pos, intrapelv nodes – SOAP Notes & Clinical Use
ICD-10 Code C84.66 is utilized in SOAP notes to document the diagnosis of Anaplastic large cell lymphoma, ALK-positive, affecting the intrapelvic nodes. This code aids in capturing the clinical picture, guiding treatment decisions, and ensuring appropriate billing in both acute and chronic care settings.
What Does ICD-10 Code C84.66 for Anaplastic large cell lymphoma, ALK-pos, intrapelv nodes Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C84.66 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Anaplastic large cell lymphoma, ALK-positive. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code C84.66 – Anaplastic large cell lymphoma, ALK-pos, intrapelv nodes
The management of Anaplastic large cell lymphoma, ALK-positive, requires urgent intervention due to its aggressive nature. Treatment typically involves chemotherapy and may include targeted therapies.
Antibiotic Therapy:
- Not applicable as this is not an infectious condition.
Supportive Care:
- Management of symptoms such as pain and fever.
- Nutritional support to maintain strength.
- Psychosocial support for patients and families.
Infection Control:
- Standard precautions to prevent infections during treatment.
- Monitoring for febrile neutropenia during chemotherapy.
How to Document Symptoms of Anaplastic large cell lymphoma, ALK-pos, intrapelv nodes (ICD-10 C84.66) in SOAP Notes
Subjective:
- Patient reports persistent fatigue and unexplained weight loss.
- Complaints of night sweats and fever over the past month.
- Notable increase in abdominal discomfort and pelvic pressure.
Objective:
- Physical examination reveals enlarged intrapelvic lymph nodes.
- Laboratory tests show elevated lactate dehydrogenase (LDH) levels.
- Imaging studies confirm lymphadenopathy in the pelvic region.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Anaplastic large cell lymphoma, ALK-pos, intrapelv nodes (ICD-10 Code C84.66)
Assessment:
- Diagnosis of Anaplastic large cell lymphoma, ALK-positive, affecting intrapelvic nodes, classified as aggressive.
- ICD-10 Code C84.66 is applicable.
- Contributing factors include age and genetic predisposition.
Plan:
- Initiate chemotherapy regimen based on current oncology protocols.
- Provide education on potential side effects and symptom management.
- Schedule follow-up appointments for monitoring treatment response.
Treatment & Plan Section for ICD-10 Code C84.66 – Anaplastic large cell lymphoma, ALK-pos, intrapelv nodes
- First-line treatment typically includes multi-agent chemotherapy regimens.
- Consideration of targeted therapy with ALK inhibitors for eligible patients.
- Regular monitoring of blood counts and imaging to assess treatment response.
- Patient education on recognizing symptoms of infection or treatment side effects.
Using ICD-10 Code C84.66 for Anaplastic large cell lymphoma, ALK-pos, intrapelv nodes in Billing & SOAP Note Compliance
- Ensure accurate documentation of symptoms and clinical findings in Subjective (S) and Objective (O) sections.
- Utilize ICD-10 Code C84.66 in all relevant billing and coding submissions.
- Align treatment plans with clinical guidelines to support justified billing.
- Document any comorbidities or complications that may affect treatment.
Related ICD-10 Codes Often Used with Anaplastic large cell lymphoma, ALK-pos, intrapelv nodes
- C84.65 – Anaplastic large cell lymphoma, ALK-neg, intrapelv nodes
- C83.90 – Diffuse large B-cell lymphoma, unspecified, unspecified site
ICD-10 Code C84.66 in Medical Billing and Insurance for Anaplastic large cell lymphoma, ALK-pos, intrapelv nodes
ICD-10 Code C84.66 is critical in medical billing, particularly in oncology and hospital settings, ensuring accurate claims for treatment of Anaplastic large cell lymphoma.
Billing Notes:
- Document all relevant clinical findings and treatment plans to support the use of this code.
- Use this code in inpatient and outpatient settings for accurate billing.
- Ensure that all documentation aligns with coding guidelines to prevent claim denials.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 85025 | Complete blood count with automated differential white blood cell count. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C84.66 for Anaplastic large cell lymphoma, ALK-pos, intrapelv nodes
What are the common symptoms of Anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, unexplained weight loss, and fatigue. Patients may also experience abdominal discomfort if lymph nodes in the pelvic region are affected.
How is Anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of anaplastic large cells and ALK positivity.
What treatments are available for Anaplastic large cell lymphoma?
Treatment often includes chemotherapy, and in some cases, targeted therapy with ALK inhibitors. Supportive care is also essential to manage symptoms and side effects.
Is Anaplastic large cell lymphoma curable?
While Anaplastic large cell lymphoma can be aggressive, many patients respond well to treatment, and some may achieve remission. Ongoing monitoring and follow-up care are crucial.
